About US
Contact us
-
Novartis, Regeneron wage acrimonious patent fight over Eylea's prefilled syringeRegeneron’s prefilled Eylea syringe has gained fast traction since its introduction in late 2019. But the new delivery method forthe eye med has drawn ire from Novartis, co-developer of rival Lucenti2020/7/24
-
Jazz’s Xywav, a low-sodium alternative to blockbuster Xyrem, snags FDA nod in narcolepsyJazz Pharmaceuticals’ Xyrem has become the standard of care for two symptoms of narcolepsy since its FDA approval in 2002. But the company’s introducing a sister drug that potentially offers better h2020/7/23
-
Biogen unexpectedly replaces CFO Capello with IQVIA vet, sparking M&A speculationWhen Biogen appointed Jeffrey Capello as its new chief financial officer in late 2017, CEO Michel Vounatsos said he would be key to the company’s efforts to seek out new business development opportun2020/7/23
-
FDA rails at California CDMO for failing to secure data used to determine strength of its drugsGenerally speaking, the quality of a manufacturer's data is only as good as the policies in place to ensure the information. Allowing all employees to access those data files—and even possibly delete2020/7/22
-
Biogen's lagging Vumerity, stalled by the pandemic, faces 'critical' stretch ahead, CEO saysBiogen’s Tecfidera follow-up Vumerity hitthe marketlate lastyear, but eight months into the launch, the new multiple sclerosis drug isyet to meaningfully take off. The druggeneratedonly $11 million i2020/7/22
-
Pfizer, BioNTech snare $1.95B deal with U.S. government for 100M-plus doses of COVID-19 vaccineThe Trump administration's Warp Speed initiative has placed its biggest bet yet on an accelerated COVID-19 vaccine—and Pfizer and BioNTech are the lucky recipients. The vaccine partnerslandedan initi2020/7/21
-
U.S. indictment says Chinese hackers tried to steal COVID-19 vaccine and drug researchOnly days after three governments said Russian hackers were targeting groups conducting COVID-19 vaccine research, the U.S. hasindictedtwo Chinese nationals for hacking hundreds of companies, governm2020/7/21
-
Pandemic hits Novartis sales with eye meds, Cosentyx suffering from slowdownStockpiling of medicines boosted Novartis’ sales during the early days of COVID-19, but a hangover followed. Lagging eye drugs, slower psoriasis sales and more dragged the Swiss drugmaker's sales dow2020/7/20
-
We're looking for 2020's Fiercest Women in Life SciencesGlaxoSmithKline chief Emma Walmsley finally has some company. Three years after she became the first woman to run a Big Pharma company, she was joined by Vertex’s new CEO, Reshma Kewalramani, M.D., w2020/7/20
-
Novartis promises zero profit for 15 symptomatic COVID-19 drugs in low-income countriesNovartis’ generic hydroxychloroquine may have little use in COVID-19, but the Swiss pharma still wants to contribute its low-cost drugs in some way in the current fight. Novartis’ Sandoz unit willoff2020/7/17